GlassScriptPhysician profile
Jeffrey D Caudill
NPI 1326144700
$7,649.34
in general payments reported to CMS, 2019-2025
45 companies · $789 in 2025
The $789 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $937 · 2021: $1,915 · 2022: $1,459 · 2023: $733 · 2024: $745 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,267.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,452.82 | 2019-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $1,368.43 | 2019-2025 | Xtampza, Belbuca |
| Abbvie INC. | $1,004.79 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Amgen INC. | $352.23 | 2019-2022 | |
| Boston Scientific Corporation | $311.92 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $298.33 | 2019-2021 | |
| Horizon Therapeutics Plc | $292.07 | 2020-2023 | Krystexxa |
| Biohaven Pharmaceuticals, INC. | $244.99 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $210.49 | 2022 | |
| Protega Pharmaceutials INC | $182.47 | 2023-2025 | Roxybond |
| Pfizer INC. | $182.41 | 2019-2025 | |
| Almatica Pharma LLC | $168.26 | 2021-2023 | Gralise |
| Bard Peripheral Vascular, INC. | $151.12 | 2021 | |
| Redhill Biopharma INC. | $129.89 | 2020-2021 | |
| Allergan, INC. | $109.34 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Caudill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.